Cargando…

Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study

OBJECTIVES: Examine the probability of new active substances (NASs) approved in Canada between 1 January 1997 and 31 March 2012 acquiring a serious postmarket safety warning. DESIGN: Cohort study. DATA SOURCES: Annual reports of the Therapeutic Products Directorate and the Biologic and Genetic Thera...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lexchin, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931983/ https://www.ncbi.nlm.nih.gov/pubmed/24549164 http://dx.doi.org/10.1136/bmjopen-2013-004289

Ejemplares similares

Time to market for drugs approved in Canada between 2014 and 2018: an observational study
por: Lexchin, Joel
Publicado: (2021)

Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study
por: Lexchin, Joel
Publicado: (2018)

National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study
por: Lexchin, Joel, et al.
Publicado: (2022)

Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study
por: Diep, Dion, et al.
Publicado: (2020)

Association of expedited review programmes with postmarketing safety events of new drugs approved by the US food and drug administration between 2007 and 2017
por: Zhu, Xingyue, et al.
Publicado: (2022)

Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis
por: Lexchin, Joel
Publicado: (2017)

Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study
por: Lexchin, Joel
Publicado: (2019)

Health Canada’s use of expedited review pathways and therapeutic innovation, 1995–2016: cross-sectional analysis
por: Lexchin, Joel
Publicado: (2018)

Postmarket Surveillance of Medical Devices: A Comparison of Strategies in the US, EU, Japan, and China
por: Kramer, Daniel B., et al.
Publicado: (2013)

How safe are new drugs? Market withdrawal of drugs approved in Canada between 1990 and 2009
por: Lexchin, Joel
Publicado: (2014)

How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study
por: Lexchin, Joel
Publicado: (2016)

After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada
por: Lexchin, Joel
Publicado: (2022)

Successful childhood obesity management in primary care in Canada: what are the odds?
por: Kuhle, Stefan, et al.
Publicado: (2015)

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States
por: Gagnon, Marc-André, et al.
Publicado: (2008)

Policies supporting informal caregivers across Canada: a scoping review protocol
por: Khayatzadeh-Mahani, Akram, et al.
Publicado: (2018)

Gender and racialisation of pharmaceutical sector leaders in Canada: a cross-sectional study
por: Satgunanathan, Kasthuri, et al.
Publicado: (2023)

Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance
por: Milliken, Debbie, et al.
Publicado: (2015)

Canada has an opportunity to address antimicrobial resistance through COVID-19 recovery spending
por: Somanader, Deborah S., et al.
Publicado: (2022)

An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice
por: Soprovich, Allison, et al.
Publicado: (2017)

Piecing together the Inuit food security policy puzzle in Nunatsiavut, Labrador (Canada): protocol for a scoping review
por: Bowers, Renee, et al.
Publicado: (2019)

Primary care performance of alternatively licenced physicians in Ontario, Canada: a cross-sectional study using administrative data
por: Hodwitz, Kathryn, et al.
Publicado: (2019)

Integrating Indigenous healing practices within collaborative care models in primary healthcare in Canada: a rapid scoping review
por: Corso, Melissa, et al.
Publicado: (2022)

Choosing appropriate tools and referral criteria for vision screening of children aged 4–5 years in Canada: a quantitative analysis
por: Nishimura, Mayu, et al.
Publicado: (2019)

The rights and interests of First Nations, Métis, and Inuit in debates over deemed consent legislation for deceased organ donation in Canada: calls to action
por: Tait, Caroline L.
Publicado: (2023)

Increase in Drug Spending in Canada Due to Extension of Data Protection for Biologics: A Descriptive Study
por: Lexchin, Joel
Publicado: (2019)

Smoking close to others and butt littering at bus stops: pilot observational study
por: Wilson, Nick, et al.
Publicado: (2014)

Other considerations than: how much will universal health coverage cost?
por: Barber, Sarah L, et al.
Publicado: (2020)

Safety monitoring of COVID-19 vaccines in Japan
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

What is the impact on the readmission ratio of taking into account readmissions to other hospitals? A cross-sectional study
por: Hekkert, Karin, et al.
Publicado: (2019)

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries
por: Giersing, Birgitte K, et al.
Publicado: (2023)

Associations of volume and other hospital characteristics on mortality within 30 days of acute myocardial infarction in South Korea
por: Han, Kyu-Tae, et al.
Publicado: (2015)

Infection control teams for reducing healthcare-associated infections in hospitals and other healthcare settings: a protocol for systematic review
por: Thandar, Moe Moe, et al.
Publicado: (2021)

Observational Evidence of For-Profit Delivery and Inferior Nursing Home Care: When Is There Enough Evidence for Policy Change?
por: Ronald, Lisa A., et al.
Publicado: (2016)

Identifying research priorities for road safety in Nepal: a Delphi study
por: Pant, Puspa Raj, et al.
Publicado: (2022)

Prediction of therapeutic value of new drugs approved by health Canada from 2011−2020: A cross-sectional study
por: Lexchin, Joel
Publicado: (2023)

Ten years of integrated care: backwards and forwards. The case of the province of Québec, Canada
por: Vedel, Isabelle, et al.
Publicado: (2011)

Can differences in length of stay between Dutch university hospitals and other hospitals be explained by patient characteristics? A cross-sectional study
por: Ghielen, Janine, et al.
Publicado: (2019)

2214 Nutritional outcomes in pediatric oncology patients less than 3 years of age
por: Runco, Daniel, et al.
Publicado: (2018)

Why do children attend school, engage in other activities or socialise when they have symptoms of an infectious illness? A cross-sectional survey
por: Woodland, Lisa, et al.
Publicado: (2023)

Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts
por: Heneghan, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3c2frrs70f8j48sqo8n6bed6b4